Palliative treatment for metastatic skin cancer and fungating skin tumor

  • ISEI Taiki
    <i>Department of Dermatology, Kansai Medical University</i>

Bibliographic Information

Other Title
  • 転移性皮膚癌とfungating tumor

Description

Cutaneous metastases from various kinds of carcinomas occur in many patients at the end of life. Therefore, the indication for radical treatment is severely restricted. Because of the poor general condition and unfavorable prognosis, the physician in charge will often avoid treatment for skin metastases or the patient may decline the treatment. However, this may lead to a more severe condition such as fungating tumor, which can develop massive discharge, bleeding, pain, infection, and malodor, causing distress to patients and a decreased quality of life (QOL). Thus, dermatologists should not abandon palliative and radical treatment for cutaneous metastases. The first choice of treatment is surgery, but palliative care that allows a patient to lead a better QOL should also be properly chosen. The aim of this paper is to discuss current wound care for cutaneous metastases with the goal of developing an appropriate strategy for better control of wound-related symptoms.[Skin Cancer (Japan) 2011 ; 26 : 282-288]

Journal

  • Skin Cancer

    Skin Cancer 26 (3), 282-288, 2011

    The Japanese Skin Cancer Society

Citations (1)*help

See more

References(6)*help

See more

Details 詳細情報について

  • CRID
    1390282679312677760
  • NII Article ID
    130002149380
  • DOI
    10.5227/skincancer.26.282
  • ISSN
    18843549
    09153535
  • Text Lang
    ja
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top